Vascular effects of prostacyclin: Does activation of PPARδ play a role?

Trends in Pharmacological Sciences

Volumn 33, Issue 10, 2012, Pages 559-564

  Katusic, Zvonimir S ^a   Santhanam, Anantha V ^a   He, Tongrong ^a  

^a MAYO GRADUATE SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

[2 METHYL 4 [4 METHYL 2 (4 TRIFLUOROMETHYLPHENYL) 5 THIAZOLYLMETHYLTHIO]PHENOXY]ACETIC ACID; BERAPROST; CICAPROST; ILOPROST; NONSTEROID ANTIINFLAMMATORY AGENT; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA AGONIST; PIMILPROST; PROSTACYCLIN; PROSTACYCLIN DERIVATIVE; PROSTAGLANDIN SYNTHASE INHIBITOR; TREPROSTINIL;

ADVERSE OUTCOME; ANGIOGENESIS; CARDIOVASCULAR DISEASE; CEREBROVASCULAR ACCIDENT; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENCY; DRUG SAFETY; DYSLIPIDEMIA; HEART INFARCTION; HUMAN; LIGAND BINDING; METABOLIC SYNDROME X; NONHUMAN; PHENOTYPIC VARIATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PULMONARY HYPERTENSION; REVIEW; SIGNAL TRANSDUCTION;

ANGIOGENESIS MODULATING AGENTS; ANIMALS; CARDIOVASCULAR SYSTEM; EPOPROSTENOL; HUMANS; PPAR DELTA; VASODILATOR AGENTS;

EID: 84866742055     PISSN: 01656147     EISSN: 18733735     Source Type: Journal    
DOI: 10.1016/j.tips.2012.05.005     Document Type: Review

References (80)

1. S. Moncada An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation Nature 263 1976 663 665
2. J.T. Shepherd, and Z.S. Katusic Endothelium-derived vasoactive factors: I. Endothelium-dependent relaxation Hypertension 18 1991 III76 III85
3. 2 and prostacyclin in the development of atherosclerosis in apoE-deficient mice J. Clin. Invest. 114 2004 784 794 (Pubitemid 39578737)
4. K.M. Egan COX-2-derived prostacyclin confers atheroprotection on female mice Science 306 2004 1954 1957 (Pubitemid 39627863)
5. D. Sun Enhanced release of prostaglandins contributes to flow-induced arteriolar dilation in eNOS knockout mice Circ. Res. 85 1999 288 293 (Pubitemid 29377301)
6. T. Murohara Vascular endothelial growth factor/vascular permeability factor enhances vascular permeability via nitric oxide and prostacyclin Circulation 97 1998 99 107 (Pubitemid 28036160)
7. 2 promotes recruitment of endothelial progenitor cells and limits vascular remodeling Arterioscler. Thromb. Vasc. Biol. 30 2010 464 470
8. J. Kawabe Prostacyclin in vascular diseases. Recent insights and future perspectives Circ. J. 74 2010 836 843
9. T. He Angiogenic function of prostacyclin biosynthesis in human endothelial progenitor cells Circ. Res. 103 2008 80 88
10. A.V. Santhanam Endothelial progenitor cells stimulate cerebrovascular production of prostacyclin by paracrine activation of cyclooxygenase-2 Circ. Res. 100 2007 1379 1388 (Pubitemid 46742928)
11. R. Di Stefano The prostacyclin analogue iloprost increases circulating endothelial progenitor cells in patients with critical limb ischemia Thromb. Haemost. 100 2008 871 877
12. D.M. Smadja Treprostinil increases the number and angiogenic potential of endothelial progenitor cells in children with pulmonary hypertension Angiogenesis 14 2011 17 27
13. A.G. Spencer Subcellular localization of prostaglandin endoperoxide H synthases-1 and -2 by immunoelectron microscopy J. Biol. Chem. 273 1998 9886 9893 (Pubitemid 28183086)
14. J.-Y. Liou Colocalization of prostacyclin synthase with prostaglandin H synthase-1 (PGHS-1) but not phorbol ester-induced PGHS-2 in cultured endothelial cells J. Biol. Chem. 275 2000 15314 15320 (Pubitemid 30337258)
15. 2 Biochim. Biophys. Acta 1488 2000 124 138
16. A.R. Schievella Calcium-mediated translocation of cytosolic phospholipase A2 to the nuclear envelope and endoplasmic reticulum J. Biol. Chem. 270 1995 30749 30754 (Pubitemid 26005142)
17. 2-α and cyclooxygenase-2 localize to intracellular membranes of EA.hy.926 endothelial cells that are distinct from the endoplasmic reticulum and the Golgi apparatus FEBS Lett. 272 2005 1278 1290 (Pubitemid 40314945)
18. H. Lim Cyclo-oxygenase-2-derived prostacyclin mediates embryo implantation in the mouse via PPARδ Genes Dev. 13 1999 1561 1574 (Pubitemid 29297924)
19. H. Lim, and S.K. Dey PPARδ functions as a prostacyclin receptor in blastocyst implantation Trends Endocrinol. Metab. 11 2000 137 142 (Pubitemid 30238546)
20. M.C. Tsai Shear stress induces synthetic-to-contractile phenotypic modulation in smooth muscle cells via peroxisome proliferator-activated receptor alpha/delta activations by prostacyclin released by sheared endothelial cells Circ. Res. 105 2009 471 480
21. C. Yokoyama Prostacyclin-deficient mice develop ischemic renal disorders, including nephrosclerosis and renal infarction Circulation 106 2002 2397 2403 (Pubitemid 35244744)
22. T. Murata Altered pain perception and inflammatory response in mice lacking prostacyclin receptor Nature 388 1997 678 682 (Pubitemid 27366439)
23. 2 Science 296 2002 539 541 (Pubitemid 34408674)
24. H. Francois Prostacyclin protects against elevated blood pressure and cardiac fibrosis Cell Metab. 2 2005 201 207
25. P. Zoldhelyi Prevention of arterial thrombosis by adenovirus-mediated transfer of cyclooxygenase gene Circulation 93 1996 10 17 (Pubitemid 26006561)
26. N. Nagaya Gene transfer of human prostacyclin synthase ameliorates monocrotaline-induced pulmonary hypertension in rats Circulation 102 2000 2005 2010
27. M. Yamada Prostacyclin synthase gene transfer modulates cyclooxygenase-2 derived prostanoid synthesis and inhibits neointimal formation in rat balloon-injured arteries Arterioscler. Thromb. Vasc. Biol. 22 2002 256 262 (Pubitemid 34127036)
28. H. Lin Cyclooxygenase-1 and bicistronic cyclooxygenase-1/prostacyclin synthase gene transfer protect against ischemic cerebral infarction Circulation 105 2002 1962 1969 (Pubitemid 34437625)
29. G.D. Barish PPARδ: a dagger in the heart of the metabolic syndrome J. Clin. Invest. 116 2006 590 597 (Pubitemid 43326863)
30. L. Brunelli Peroxisome proliferator-activated receptor-δ upregulates 14-3-3ε in human endothelial cells via CCAAT/enhancer binding protein-β Circ. Res. 100 2007 e59 e71
31. D. Wang Crosstalk between peroxisome proliferator-activated receptor δ and VEGF stimulates cancer progression Proc. Natl. Acad. Sci. U.S.A. 103 2006 19069 19074 (Pubitemid 350002829)
32. G.D. Barish PPARdelta regulates multiple proinflammatory pathways to suppress atherosclerosis Proc. Natl. Acad. Sci. U.S.A. 105 2008 4271 4276 (Pubitemid 351754370)
33. Y. Takata PPARdelta-mediated antiinflammatory mechanisms inhibit angiotensin II-accelerated atherosclerosis Proc. Natl. Acad. Sci. U.S.A. 105 2008 4277 4282 (Pubitemid 351754371)
34. C.H. Lee Transcriptional repression of atherogenic inflammation: modulation by PPARdelta Science 302 2003 453 457
35. J.Y. Liou Protection of endothelial survival by peroxisome proliferator-activated receptor-delta mediated 14-3-3 upregulation Arterioscler. Thromb. Vasc. Biol. 26 2006 1481 1487
36. L. Piqueras Activation of PPARbeta/delta induces endothelial cell proliferation and angiogenesis Arterioscler. Thromb. Vasc. Biol. 27 2007 63 69 (Pubitemid 46370477)
37. Y. Fan Suppression of pro-inflammatory adhesion molecules by PPAR-delta in human vascular endothelial cells Arterioscler. Thromb. Vasc. Biol. 28 2008 315 321 (Pubitemid 351161205)
38. D. Bishop-Bailey PPARs and angiogenesis Biochem. Soc. Trans. 39 2011 1601 1605
39. J. Zhang Peroxisome proliferator-activated receptor delta is upregulated during vascular lesion formation and promotes post-confluent cell proliferation in vascular smooth muscle cells J. Biol. Chem. 277 2002 11505 11512 (Pubitemid 34952920)
40. H.J. Lim PPAR delta agonist L-165041 inhibits rat vascular smooth muscle cell proliferation and migration via inhibition of cell cycle Atherosclerosis 202 2009 446 454
41. H.J. Kim Transforming growth factor-β1 is a molecular target for the peroxisome proliferator-activated receptor δ Circ. Res. 102 2008 193 200 (Pubitemid 351651123)
42. H.J. Kim Peroxisome proliferator-activated receptor {delta} regulates extracellular matrix and apoptosis of vascular smooth muscle cells through the activation of transforming growth factor-β1/Smad3 Circ. Res. 105 2009 16 24
43. A. Abdollahi Transcriptional network governing the angiogenic switch in human pancreatic cancer Proc. Natl. Acad. Sci. U.S.A. 104 2007 12890 12895 (Pubitemid 47255250)
44. D. Bishop-Bailey, and K.E. Swales The role of PPARs in the endothelium: implications for cancer therapy PPAR Res. 2008 2008 904251 904263
45. K.-D. Wagner, and N. Wagner Peroxisome proliferator-activated receptor beta/delta (PPARβ/δ) acts as regulator of metabolism linked to multiple cellular functions Pharmacol. Ther. 125 2010 423 435
46. W.R. Oliver Jr. A selective peroxisome proliferator-activated receptor δ agonist promotes reverse cholesterol transport Proc. Natl. Acad. Sci. U.S.A. 98 2001 5306 5311 (Pubitemid 32397124)
47. D.L. Sprecher Triglyceride:high-density lipoprotein cholesterol effects in healthy subjects administered a peroxisome proliferator activated receptor δ agonist Arterioscler. Thromb. Vasc. Biol. 27 2007 359 365 (Pubitemid 46143052)
48. U. Risérus Activation of peroxisome proliferator-activated receptor (PPAR)δ promotes reversal of multiple metabolic abnormalities, reduces oxidative stress, and increases fatty acid oxidation in moderately obese men Diabetes 57 2008 332 339
49. J.D. Brown VLDL hydrolysis by hepatic lipase regulates PPARδ transcriptional responses PLoS ONE 6 2011 1 13
50. E.M.M. Ooi Mechanism of action of a peroxisome proliferator-activated receptor (PPAR)-δ agonist on lipoprotein metabolism in dyslipidemic subjects with central obesity J. Clin. Endocrinol. Metab. 96 2011 E1568 E1576
51. N. Sato The prostacyclin analog beraprost sodium ameliorates characteristics of metabolic syndrome in obese Zucker (fatty) rats Diabetes 59 2010 1092 1100
52. 2 analog beraprost sodium Prostaglandins Other Lipid. Mediat. 93 2010 14 19
53. S. Moncada Adventures in vascular biology: a tale of two mediators Philos. Trans. R. Soc. Lond. B: Biol. Sci. 361 2008 735 759 (Pubitemid 44858917)
54. R. Hertz Activation of gene transcription by prostacyclin analogues is mediated by the peroxisome-proliferators-activated receptor (PPAR) Eur. J. Biochem. 15 1996 242 247 (Pubitemid 26045440)
55. B.M. Forman Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors alpha and delta Proc. Natl. Acad. Sci. U.S.A. 94 1997 4312 4317 (Pubitemid 27194238)
56. L. Jin Structural basis for Iloprost as a dual peroxisome proliferator-activated receptor α/δ agonist J. Biol. Chem. 286 2011 31473 31479
57. F.Y. Ali Role of prostacyclin versus peroxisome proliferator-activated receptor β receptors in prostacyclin sensing by lung fibroblasts Am. J. Respir. Cell Mol. Biol. 34 2006 242 246 (Pubitemid 43202472)
58. R. Pola Comparative analysis of the in vivo angiogenic properties of stable prostacyclin analogs: a possible role for peroxisome proliferator- activated receptors J. Mol. Cell. Cardiol. 36 2004 363 370 (Pubitemid 38316941)
59. J.-C. Huang Prostacyclin receptor signaling and early embryo development in the mouse Hum. Reprod. 22 2007 2851 2856 (Pubitemid 351696831)
60. G. Lazennec Activation of peroxisome proliferator-activated receptors (PPARs) by their ligands and protein kinase A activators Mol. Endocrinol. 14 2000 1962 1975 (Pubitemid 32055530)
61. J.B. Hansen Peroxisome proliferator-activated receptor δ (PPARδ)-mediated regulation of preadipocyte proliferation and gene expression is dependent on cAMP signaling J. Biol. Chem. 276 2001 3175 3182
62. A.-M. Krogsdam Nuclear receptor corepressor-dependent repression of peroxisome-proliferator-activated receptor δ-mediated transactivation Biochem. J. 363 2002 157 165 (Pubitemid 34280622)
63. C. Blanquart Peroxisome proliferator-activated receptors: regulation of transcriptional activities and roles in inflammation J. Steroid Biochem. Mol. Biol. 85 2003 267 273 (Pubitemid 37011102)
64. F. Biscetti Peroxisome proliferator-activated receptor alpha is crucial for iloprost-induced in vivo angiogenesis and vascular endothelial growth factor upregulation J. Vasc. Res. 46 2008 103 108
65. L. Kuwashima Stimulation of endothelial cell prostacyclin release by retina-derived factors Invest. Ophthalmol. Vis. Sci. 29 1988 1213 1220
66. R. Bicknell, and B.L. Vallee Angiotensin stimulates endothelial cell prostacyclin secretion by activation of phospholipase A2 Proc. Natl. Acad. Sci. U.S.A. 86 1989 1573 1577 (Pubitemid 19078945)
67. H. He Vascular endothelial growth factor signals endothelial cell production of nitric oxide and prostacyclin through flk-1/KDR activation of c-Src J. Biol. Chem. 274 1999 25130 25135
68. T. Yamamoto Effect of topical application of a stable prostacyclin analogue, SM-10902 on wound healing in diabetic mice Eur. J. Pharmacol. 302 1996 53 60 (Pubitemid 26184339)
69. E. Spisni Colocalization of prostacyclin (PGI2) synthase-caveolin-1 in endothelial cells and new roles for PGI2 in angiogenesis Exp. Cell Res. 266 2001 31 43 (Pubitemid 32989040)
70. T. He Activation of peroxisome proliferator-activated receptor-δ enhances regenerative capacity of human endothelial progenitor cells by stimulating biosynthesis of tetrahydrobiopterin Hypertension 58 2011 287 294
71. J.K. Han Peroxisome proliferator-activated receptor-δ agonist enhances vasculogenesis by regulating endothelial progenitor cells through genomic and nongenomic activations of the phosphatidylinositol 3-kinase/Akt pathway Circulation 118 2008 1021 1033
72. Han, J.K. et al. (2011) Peroxisome proliferator-activated receptor-δ activates endothelial progenitor cells to induce angiomyogenesis through matrix metalol-proteinase-9-mediated insulin-like growth factor-1 paracrine networks. Eur. Heart J.(in press)
73. J.E. Foreman Regulation of peroxisome proliferator-activated receptor-β/δ by the APC/β-CATENIN pathway and nonsteroidal antiinflammatory drugs Mol. Carcinog. 48 2009 942 952
74. K.K. Wu, and J.Y. Liou Cyclooxygenase inhibitors induce colon cancer cell apoptosis via PPARδ→14-3-3ε pathway Methods Mol. Biol. 512 2009 295 307
75. A.P. Fishman Pulmonary hypertension - beyond vasodilator therapy N. Engl. J. Med. 338 1998 321 322 (Pubitemid 28065259)
76. Y. Okano Orally active prostacyclin analogue in primary pulmonary hypertension Lancet 349 1997 1365 (Pubitemid 27197541)
77. W.B. White Cardiovascular effects of the cyclooxygenase inhibitors Hypertension 49 2007 408 418
78. T. Grosser Emotion recollected in tranquility: lessons learned from the COX-2 saga Annu. Rev. Med. 61 2010 17 33
79. J.-Y. Liou Nonsteroidal anti-inflammatory drugs induced endothelial apoptosis by perturbing peroxisome proliferator-activated receptor-δ transcriptional pathway Mol. Pharmacol. 74 2008 1399 1406
80. E. Nilsson Regulation of skeletal muscle PPAR delta mRNA expression in twins J. Physiol. 584 2007 1011 1017 (Pubitemid 350031938)